Quick Answer
ICU MEDICAL INC/DE reported Cash and Equivalents of $308.57 million for fiscal year 2024.
ICU MEDICAL INC/DE Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $308.57M | +21.1% |
| 2023 | $254.72M | +22.0% |
| 2022 | $208.78M | -62.2% |
| 2021 | $552.83M | +39.6% |
| 2020 | $396.10M | +47.4% |
| 2019 | $268.67M | -22.1% |
| 2018 | $344.78M | +18.9% |
| 2017 | $290.07M | -34.8% |
| 2016 | $445.08M | +32.4% |
| 2015 | $336.16M | +21.9% |
| 2014 | $275.81M | +22.0% |
| 2013 | $226.02M | +53.9% |
| 2012 | $146.90M | +47.5% |
| 2011 | $99.59M | +26.3% |
| 2010 | $78.85M | +53.9% |
| 2009 | $51.25M | -8.0% |
| 2008 | $55.70M | +607.4% |
| 2007 | $7.87M | -40.1% |
| 2006 | $13.15M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $312.51M | +57.0% | +3.3% |
| June 30, 2024 | $302.65M | +53.1% | +20.4% |
| March 31, 2024 | $251.42M | +12.2% | -1.3% |
| December 31, 2023 | $254.72M | +19.6% | +28.0% |
| September 30, 2023 | $199.00M | -19.4% | +0.7% |
| June 30, 2023 | $197.70M | -26.5% | -11.8% |
| March 31, 2023 | $224.18M | -34.9% | +5.2% |
| December 31, 2022 | $213.01M | -62.4% | -13.7% |
- ICU MEDICAL INC/DE showed an increase of +21.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2006–2024 period, ICU MEDICAL INC/DE’s cash and equivalents has grown by 2246.0% (from $13.15 million to $308.57 million).
- The most recent figure is from ICU MEDICAL INC/DE’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: